66.7% (n=10) of patients with prostatic adenocarcinoma in grade 7 showed positive overexpression of EMA protein (Figure 2), whereas 33.3% (n=5) exhibited negative expression (Figure 3). Here, MUC1 is linked to prostate adenocarcinoma.